Skip to main content

Josephson Neil's Form 4/A amendment

Amended

Zymeworks Inc. (ZYME) · filed Dec 23, 2022

Accession no.
0000899243-22-039331
Filed
Dec 23, 2022
Trade date
Nov 10, 2022
Filing delay
43 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Nov 14, 2022

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $20.0K. It was filed 43 days after the trade.

This amendment replaces 0000899243-22-035813 (filed Nov 14, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Josephson NeilCIK 0001864141Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 10, 2022Common StockMOption exerciseAcquired+5,885$0.00$016,924Direct
Nov 10, 2022Common StockSSaleDisposed−2,475$8.10−$20,047.514,449Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 10, 2022Common SharesMOption exerciseDisposed−5,885$0.00$011,772Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)